Last reviewed · How we verify

trisodium citrate — Competitive Intelligence Brief

trisodium citrate (trisodium citrate) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Anticoagulant / Alkalinizing agent. Area: Hematology / Nephrology.

marketed Anticoagulant / Alkalinizing agent Ionized calcium (Ca2+) Hematology / Nephrology Small molecule Live · refreshed every 30 min

Target snapshot

trisodium citrate (trisodium citrate) — Onze Lieve Vrouwe Gasthuis. Trisodium citrate acts as an anticoagulant by chelating calcium ions, preventing blood clotting in vitro and in extracorporeal circuits.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
trisodium citrate TARGET trisodium citrate Onze Lieve Vrouwe Gasthuis marketed Anticoagulant / Alkalinizing agent Ionized calcium (Ca2+)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Anticoagulant / Alkalinizing agent class)

  1. Onze Lieve Vrouwe Gasthuis · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). trisodium citrate — Competitive Intelligence Brief. https://druglandscape.com/ci/trisodium-citrate. Accessed 2026-05-15.

Build your own brief

Pick any drug + add comparators: